MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
56.49
+2.64
+4.89%
Opening 12:49 06/30 EDT
OPEN
54.24
PREV CLOSE
53.85
HIGH
57.34
LOW
53.47
VOLUME
415.16K
TURNOVER
--
52 WEEK HIGH
57.34
52 WEEK LOW
9.63
MARKET CAP
2.69B
P/E (TTM)
-25.5808
1D
5D
1M
3M
1Y
5Y
1D
Biotech Is The Rate Cut Trade In Disguise
Seeking Alpha · 20h ago
Weekly Report: what happened at MBX last week (0622-0626)?
Weekly Report · 1d ago
Does MBX (MBX) Joining Russell Growth Indexes Mark a Lasting Shift in Its Market Narrative?
Simply Wall St · 1d ago
6 Biotech Stocks That Delivered Stunning Gains: INBX +700%, PVLA +500%, MBX +300%, ABSI +200% & More
NASDAQ · 6d ago
10 mid-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha · 6d ago
Weekly Report: what happened at MBX last week (0615-0619)?
Weekly Report · 06/22 09:49
MBX Biosciences (MBX) Is Up 21.2% After Strong Phase 2 Canvuparatide Data in Hypoparathyroidism
Simply Wall St · 06/22 04:33
Analyst Reiterates Buy on MBX, Maintains $91 Price Target on Canvuparade’s Once-Weekly Hypoparathyroidism Opportunity
TipRanks · 06/18 19:05
More
About MBX
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.